Israel has been a pioneer in fostering scientific advancement in medical cannabis, but its regulations remain fairly restrictive on access, though reform efforts are ongoing. For example, patients are generally required to obtain a licence for medical cannabis, which presents an obstacle to access, but the patient licence requirement will be lifted for certain qualifying conditions beginning some time in 2024. Other reform efforts seek to reduce obstacles for importing and exporting medical cannabis.
Jonathan has a BA in Economics from Western Kentucky University (USA) and a Master’s in International Economics from Universitat Rovira i Virgili (Spain). He has analyst and insight experience across several industries such as automotive, alcohol, and nuts and dried fruits. He has also served as a part-time professor within the Economics Faculty at Universitat Rovira i Virgili for the International Markets Master Degree.
Our Key Benefits
The global cannabis market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.
CannIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.
Stay informed of any legal and market change in the sector that impacts your organisation
Maximise resources by getting market and legal data analysis daily in one place
Make smart decisions by understanding how the regulatory and market landscape evolves
Anticipate risks in your decisions by monitoring regulatory changes that impact your organization
Thanks for getting in touch with us
Please leave your enquiry and we will get back to you within 24 hours
"*" indicates required fields
Start your FREE trial
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis to keep you on top of worldwide industry trends.
LATEST ALERTS
